Elisabeth Livingstone is a senior physician in the Department of Dermatology at the University Hospital in Essen, Germany. She has many years of experience in the management of patients with skin tumours from diagnosis to the care of patients with advanced disease, with a strong clinical and research focus on melanoma. As a sub-investigator and deputy PI, she has been involved in more than 50 phase I-IV clinical trials over the past 15 years, including the majority of pivotal trials in melanoma. Of particular note is her involvement in the development and implementation of Investigator Initiated Trials (IITs). Her research interests include the adjuvant treatment of melanoma, the identification and characterisation of melanoma subgroups with high unmet medical need, and the quality of life of skin cancer patients. Elisabeth is PI of several projects and member of the board of GRK 2535 "WisPerMed" and is an important bridge between research and the point of care. She is in close contact with national and international dermato-oncology colleagues and is involved in several interdisciplinary projects.